Homologous acetylenic acetogenins from Porcelia macrocarpa R.E. (Fries) displayed potent activity against amastigotes from Trypanosoma cruzi

Brito I.A.; Castro Levatti E.V.; Regasini L.O.; Ferreira E.A.; Lopes F.B.; Fernandes J.P.S.; Batista J.M.; Tempone A.G.; Lago J.H.G.

Homologous acetylenic acetogenins from Porcelia macrocarpa R.E. (Fries) displayed potent activity against amastigotes from Trypanosoma cruzi

Tipo

Artigo

Data de publicação

2025

Periódico

Phytochemistry

Citações (Scopus)

0

Autores

Brito I.A.
Castro Levatti E.V.
Regasini L.O.
Ferreira E.A.
Lopes F.B.
Fernandes J.P.S.
Batista J.M.
Tempone A.G.
Lago J.H.G.

Resumo

© 2024 Elsevier LtdAs part of our continuous study on the Annonaceae species Porcelia macrocarpa, in the present work, eight chemically related 2-alkyl-3-hydroxy-4-methyl-γ-lactones (1–8) were isolated. Their structures were characterised by NMR, MS, and VCD. Their antitrypanosomal activity was evaluated in vitro against intracellular amastigotes with EC50 values ranged from 13.9 to 1.1 μM for compounds 1–3 and 6–8, while compounds 4 and 5 were inactive (EC50 > 100 μM). Compounds 1–8 did not exert toxicity against NCTC cells at the highest tested concentration (CC50 > 200 μM). Compared with the standard drug benznidazole (EC50 = 3.6 μM and SI > 54.6), compound 8 proved to be the most potent γ-lactone with an EC50 of 1.1 μM and an SI of >181.8. Finally, the structure–activity relationship analysis suggested that flexibility and length of side chain of the related γ-lactones 1–8 play an important role in the activity against amastigotes. The results contribute to the discovery of new molecular prototypes that can be used as scaffolds for developing drugs to treat Chagas disease.